<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000269428"><TermName>risedronate</TermName><TermPronunciation>(rih-SEH-droh-nayt)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied in the prevention and treatment of osteoporosis. It belongs to the family of drugs called bone resorption inhibitors.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000710063" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;risedronate&quot;" language="en" id="_3"/><MediaLink ref="CDR0000710064" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;risedronato&quot;" language="es" id="_4"/><SpanishTermName>risedronato</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para la prevención y el tratamiento de la osteoporosis. Es un tipo de inhibidor de la reabsorción ósea.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2002-12-21</DateFirstPublished></GlossaryTerm>
